XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.1
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
ASSETS    
Cash and cash equivalents $ 10,188 $ 13,490
Restricted cash and equivalents 158,895 149,299
Finance receivables measured at fair value 2,575,117 2,476,617
Finance receivables 69,533 92,304
Less: Allowance for finance credit losses (14,728) (21,753)
Finance receivables, net 54,805 70,551
Furniture and equipment, net 1,463 1,660
Deferred tax assets, net 9,792 10,177
Other assets 26,362 30,974
Total Assets 2,836,622 2,752,768
Liabilities    
Accounts payable and accrued expenses 59,825 55,421
Warehouse lines of credit 285,809 285,328
Residual interest financing 49,686 49,623
Securitization trust debt 2,175,068 2,108,744
Subordinated renewable notes 23,443 25,263
Total liabilities 2,593,831 2,524,379
COMMITMENTS AND CONTINGENCIES
Shareholders' Equity    
Common stock, no par value; authorized 75,000,000 shares; 20,496,144 and 20,131,323 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively 29,485 28,906
Retained earnings 216,337 202,514
Accumulated other comprehensive loss (3,031) (3,031)
Total stockholders’ equity 242,791 228,389
Total liability and stockholder’ equity 2,836,622 2,752,768
Preferred Stock [Member]    
Shareholders' Equity    
Preferred Stock, Value, Issued 0 0
Series A Preferred Stock [Member]    
Shareholders' Equity    
Preferred Stock, Value, Issued 0 0
Series B Preferred Stock [Member]    
Shareholders' Equity    
Preferred Stock, Value, Issued $ 0 $ 0